Cryoablation Devices Market Report and Forecast 2025-2034
Description
The global cryoablation devices market size was valued at USD 457.70 Million in 2024, driven by emphasis on using minimally invasive procedures to treat cancer across the globe. The market is expected to grow at a CAGR of 10.30% during the forecast period of 2025-2034, with the values likely to rise from USD 1219.93 Million by 2034.
Cryoablation Devices: Introduction
Cryoablation devices are used to destroy an abnormal or cancerous tissue with the help of extremely cold temperatures. Cryoablation is done with the help of ultrasound or computed tomography (CT) scans to visualize the affected area. It is commonly used to treat cancer in patients, particularly advised when the cancer is too risky to operate on.
Global Cryoablation Devices Market Analysis
The rising incidence of cancer cases has led to a significant surge in the treatment methods. Since cryoablation is a minimally invasive and precise treatment, it is generally preferred by patients as well as healthcare professionals. Therefore, the cryoablation devices market demand has observed an upswing in the recent years.
Cryoablation is also applied in the treatment of atrial fibrillation. During the procedure, the pulmonary vein receives cryotherapy through the balloon catheter which freezes the abnormal tissue and blocks the irregular signals. In August 2023, Boston Scientific has received an FDA approval of their POLARx™ cryoablation system, which follows the same mechanism to treat atrial fibrillation.
The cryoablation devices market value is anticipated to grow with the soaring improvements in the existing models. AtriCure manufactured cryoICE cryoablation probes called CRYO2 and CRYO3 offer superior work capacity as they are quick to achieve the demanded temperature and contain nitrous oxide instead of Argon, leading to higher heat absorption capacity. It also contains a retractable handle along with a flexible tube to enable multiple handle positions.
ProSense® System, introducers, and disposable cryoprobes by IceCure Medical Ltd. has also received regulatory approval in Canada and China, implying that the cryoablation devices market growth will increase further in the forecast period.
Global Cryoablation Devices Market Segmentation
Cryoablation Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
The Asia Pacific market is expected to grow at an exponential rate with continuous advancements on the cancer treatment front. Being a centre for easy resources and academic talent, several healthcare companies have been investing in the region. Recently, NovoMed Incorporation Pvt. Ltd. launched IceCure Medical’s flagship machine “ProSense” in four Indian hospitals. Such collaborations indicate that the region is likely to hold a substantial cryoablation devices market share in the future.
Cancer is one of the leading causes of mortality in the United States, anticipated to observe approximately 1,958,310 new cancer cases in 2023. Therefore, there has been high prioritization on reducing the burden of the fatal disease. The presence of prominent healthcare companies, research institutions, and technically equipped healthcare infrastructure are some of the major factors that will add up contribute to the North America cryoablation devices market size. Furthermore, government initiatives to educate the public regarding cancer treatment and surgeries is another essential aspect for the high market value.
Global Cryoablation Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Cryoablation Devices: Introduction
Cryoablation devices are used to destroy an abnormal or cancerous tissue with the help of extremely cold temperatures. Cryoablation is done with the help of ultrasound or computed tomography (CT) scans to visualize the affected area. It is commonly used to treat cancer in patients, particularly advised when the cancer is too risky to operate on.
Global Cryoablation Devices Market Analysis
The rising incidence of cancer cases has led to a significant surge in the treatment methods. Since cryoablation is a minimally invasive and precise treatment, it is generally preferred by patients as well as healthcare professionals. Therefore, the cryoablation devices market demand has observed an upswing in the recent years.
Cryoablation is also applied in the treatment of atrial fibrillation. During the procedure, the pulmonary vein receives cryotherapy through the balloon catheter which freezes the abnormal tissue and blocks the irregular signals. In August 2023, Boston Scientific has received an FDA approval of their POLARx™ cryoablation system, which follows the same mechanism to treat atrial fibrillation.
The cryoablation devices market value is anticipated to grow with the soaring improvements in the existing models. AtriCure manufactured cryoICE cryoablation probes called CRYO2 and CRYO3 offer superior work capacity as they are quick to achieve the demanded temperature and contain nitrous oxide instead of Argon, leading to higher heat absorption capacity. It also contains a retractable handle along with a flexible tube to enable multiple handle positions.
ProSense® System, introducers, and disposable cryoprobes by IceCure Medical Ltd. has also received regulatory approval in Canada and China, implying that the cryoablation devices market growth will increase further in the forecast period.
Global Cryoablation Devices Market Segmentation
Cryoablation Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Tissue Contact Probe Ablators
- Epidermal and Subcutaneous Cryoablation Systems
- Tissue Spray Probe Ablators
- Prostate Cancer
- Renal Cancer
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Cardiac Arrhythmia
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The Asia Pacific market is expected to grow at an exponential rate with continuous advancements on the cancer treatment front. Being a centre for easy resources and academic talent, several healthcare companies have been investing in the region. Recently, NovoMed Incorporation Pvt. Ltd. launched IceCure Medical’s flagship machine “ProSense” in four Indian hospitals. Such collaborations indicate that the region is likely to hold a substantial cryoablation devices market share in the future.
Cancer is one of the leading causes of mortality in the United States, anticipated to observe approximately 1,958,310 new cancer cases in 2023. Therefore, there has been high prioritization on reducing the burden of the fatal disease. The presence of prominent healthcare companies, research institutions, and technically equipped healthcare infrastructure are some of the major factors that will add up contribute to the North America cryoablation devices market size. Furthermore, government initiatives to educate the public regarding cancer treatment and surgeries is another essential aspect for the high market value.
Global Cryoablation Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Atricure, INC.
- Galil Medical INC.
- Metrum Cryoflex SP
- BVM Medical Limited
- Medtronic plc
- CPSI Biotech
- CooperSurgical INC.
- HealthTronics, INC.
- Icecure Medical
- Sanarus Technologies
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Cryoablation Devices Market Overview
- 3.1 Global Cryoablation Devices Market Historical Value (2018-2024)
- 3.2 Global Cryoablation Devices Market Forecast Value (2025-2034)
- 4 Global Cryoablation Devices Market Landscape
- 4.1 Global Cryoablation Devices: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Cryoablation Devices: Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Applications
- 5 Global Cryoablation Devices Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Cryoablation Devices Market Segmentation
- 6.1 Global Cryoablation Devices Market by Type
- 6.1.1 Market Overview
- 6.1.2 Tissue Contact Probe Ablators
- 6.1.3 Epidermal and Subcutaneous Cryoablation Systems
- 6.1.4 Tissue Spray Probe Ablators
- 6.2 Global Cryoablation Devices Market by Applications
- 6.2.1 Market Overview
- 6.2.2 Prostate Cancer
- 6.2.3 Renal Cancer
- 6.2.4 Liver Cancer
- 6.2.5 Breast Cancer
- 6.2.6 Lung Cancer
- 6.2.7 Cardiac Arrhythmia
- 6.3 Global Cryoablation Devices Market by End User
- 6.3.1 Market Overview
- 6.3.2 Hospitals
- 6.3.3 Specialty Clinics
- 6.3.4 Ambulatory Surgical Centres
- 6.4 Global Cryoablation Devices Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Cryoablation Devices Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Cryoablation Devices Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Cryoablation Devices Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Cryoablation Devices Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Cryoablation Devices Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding and Investment Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Supplier Landscape
- 16.1 Atricure, INC.
- 16.1.1 Financial Analysis
- 16.1.2 Product Portfolio
- 16.1.3 Demographic Reach and Achievements
- 16.1.4 Mergers and Acquisitions
- 16.1.5 Certifications
- 16.2 Galil Medical INC.
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Mergers and Acquisitions
- 16.2.5 Certifications
- 16.3 Metrum Cryoflex SP
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Mergers and Acquisitions
- 16.3.5 Certifications
- 16.4 BVM Medical Limited
- 16.4.1 Financial Analysis
- 16.4.2 Product Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Mergers and Acquisitions
- 16.4.5 Certifications
- 16.5 Medtronic plc
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Mergers and Acquisitions
- 16.5.5 Certifications
- 16.6 CPSI Biotech
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Mergers and Acquisitions
- 16.6.5 Certifications
- 16.7 CooperSurgical INC.
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Mergers and Acquisitions
- 16.7.5 Certifications
- 16.8 HealthTronics, INC.
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Mergers and Acquisitions
- 16.8.5 Certifications
- 16.9 Icecure Medical
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Mergers and Acquisitions
- 16.9.5 Certifications
- 16.10 Sanarus Technologies
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic Reach and Achievements
- 16.10.4 Mergers and Acquisitions
- 16.10.5 Certifications
- 17 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 18 Company Competitiveness Analysis (Additional Insight)
- 18.1 Very Small Companies
- 18.2 Small Companies
- 18.3 Mid-Sized Companies
- 18.4 Large Companies
- 18.5 Very Large Companies
- 19 Payment Methods (Additional Insight)
- 19.1 Government Funded
- 19.2 Private Insurance
- 19.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
